403 related articles for article (PubMed ID: 37433759)
21. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Xu A; He F; Zhang X; Li X; Ran Y; Wei C; James Chou C; Zhang R; Wu J
Bioorg Chem; 2020 May; 98():103721. PubMed ID: 32193030
[TBL] [Abstract][Full Text] [Related]
22. Structure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE/BuChE inhibitors for Alzheimer's disease.
Conceição RAD; von Ranke N; Azevedo L; Franco D; Nadur NF; Kummerle AE; Barbosa MLC; Souza AMT
J Cell Biochem; 2023 Nov; 124(11):1734-1748. PubMed ID: 37796142
[TBL] [Abstract][Full Text] [Related]
23. New compounds from heterocyclic amines scaffold with multitarget inhibitory activity on Aβ aggregation, AChE, and BACE1 in the Alzheimer disease.
García Marín ID; Camarillo López RH; Martínez OA; Padilla-Martínez II; Correa-Basurto J; Rosales-Hernández MC
PLoS One; 2022; 17(6):e0269129. PubMed ID: 35657793
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease.
Matošević A; Opsenica DM; Spasić M; Maraković N; Zandona A; Žunec S; Bartolić M; Kovarik Z; Bosak A
Chem Biol Interact; 2023 Sep; 382():110620. PubMed ID: 37406982
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
[TBL] [Abstract][Full Text] [Related]
28. Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics.
Meena VK; Chaturvedi S; Sharma RK; Mishra AK; Hazari PP
Mol Pharm; 2019 Jun; 16(6):2296-2308. PubMed ID: 31059278
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.
Liu W; Wu L; Liu W; Tian L; Chen H; Wu Z; Wang N; Liu X; Qiu J; Feng X; Xu Z; Jiang X; Zhao Q
Eur J Med Chem; 2022 Nov; 242():114689. PubMed ID: 36007469
[TBL] [Abstract][Full Text] [Related]
30. Indoloquinoxaline derivatives as promising multi-functional anti-Alzheimer agents.
Kanhed AM; Patel DV; Patel NR; Sinha A; Thakor PS; Patel KB; Prajapati NK; Patel KV; Yadav MR
J Biomol Struct Dyn; 2022 Apr; 40(6):2498-2515. PubMed ID: 33111617
[TBL] [Abstract][Full Text] [Related]
31. Thioxanthenone-based derivatives as multitarget therapeutic leads for Alzheimer's disease.
Tonelli M; Catto M; Sabaté R; Francesconi V; Laurini E; Pricl S; Pisani L; Miniero DV; Liuzzi GM; Gatta E; Relini A; Gavín R; Del Rio JA; Sparatore F; Carotti A
Eur J Med Chem; 2023 Mar; 250():115169. PubMed ID: 36753881
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.
Choubey PK; Tripathi A; Sharma P; Shrivastava SK
Bioorg Med Chem; 2020 Nov; 28(22):115721. PubMed ID: 33007563
[TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis, and Biological Evaluation of Piperazine and
Waiker DK; Verma A; Akhilesh ; A GT; Singh N; Roy A; Dilnashin H; Tiwari V; Trigun SK; Singh SP; Krishnamurthy S; Lama P; Davisson VJ; Shrivastava SK
ACS Chem Neurosci; 2023 Jun; 14(11):2217-2242. PubMed ID: 37216500
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD.
Digiacomo M; Chen Z; Wang S; Lapucci A; Macchia M; Yang X; Chu J; Han Y; Pi R; Rapposelli S
Bioorg Med Chem Lett; 2015 Feb; 25(4):807-10. PubMed ID: 25597007
[TBL] [Abstract][Full Text] [Related]
36. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
37. Unleashing new MTDL AChE and BuChE inhibitors as potential anti-AD therapeutic agents: In vitro, in vivo and in silico studies.
Zaafar D; Elghazawy NH; Hassan A; Mahmoud MY; Bakr AF; Arafa RK
Int J Biol Macromol; 2024 May; 268(Pt 1):131740. PubMed ID: 38653428
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease.
Li X; Li T; Zhang P; Li X; Lu L; Sun Y; Zhang B; Allen S; White L; Phillips J; Zhu Z; Yao H; Xu J
Eur J Med Chem; 2022 Dec; 244():114841. PubMed ID: 36257284
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
[TBL] [Abstract][Full Text] [Related]
40. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease.
Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S
Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
